Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 53

1.

The many faces of tau.

Morris M, Maeda S, Vossel K, Mucke L.

Neuron. 2011 May 12;70(3):410-26. doi: 10.1016/j.neuron.2011.04.009. Review.

2.

Going new places using an old MAP: tau, microtubules and human neurodegenerative disease.

Garcia ML, Cleveland DW.

Curr Opin Cell Biol. 2001 Feb;13(1):41-8. Review.

PMID:
11163132
3.

Microtubule-associated protein tau in development, degeneration and protection of neurons.

Wang JZ, Liu F.

Prog Neurobiol. 2008 Jun;85(2):148-75. doi: 10.1016/j.pneurobio.2008.03.002. Epub 2008 Mar 22. Review.

PMID:
18448228
4.

Tau phosphorylation in neuronal cell function and dysfunction.

Johnson GV, Stoothoff WH.

J Cell Sci. 2004 Nov 15;117(Pt 24):5721-9. Review.

5.

Tau gene mutations: dissecting the pathogenesis of FTDP-17.

Ingram EM, Spillantini MG.

Trends Mol Med. 2002 Dec;8(12):555-62. Review.

PMID:
12470988
6.

Tau cleavage and tau aggregation in neurodegenerative disease.

Hanger DP, Wray S.

Biochem Soc Trans. 2010 Aug;38(4):1016-20. doi: 10.1042/BST0381016. Review.

PMID:
20658996
8.

Tau in neurodegenerative diseases: tau phosphorylation and assembly.

Avila J, Pérez M, Lim F, Gómez-Ramos A, Hernández F, Lucas JJ.

Neurotox Res. 2004;6(6):477-82. Review.

PMID:
15639780
9.

Intracellular and extracellular roles for tau in neurodegenerative disease.

Hanger DP, Lau DH, Phillips EC, Bondulich MK, Guo T, Woodward BW, Pooler AM, Noble W.

J Alzheimers Dis. 2014;40 Suppl 1:S37-45. doi: 10.3233/JAD-132054. Review.

PMID:
24595196
10.

Modeling Tauopathy in the fruit fly Drosophila melanogaster.

Khurana V.

J Alzheimers Dis. 2008 Dec;15(4):541-53. Review. Erratum in: J Alzheimers Dis. 2009 Mar;16(3):667-8.

PMID:
19096155
11.

The cytoskeleton in neurodegenerative diseases.

Cairns NJ, Lee VM, Trojanowski JQ.

J Pathol. 2004 Nov;204(4):438-49. Review.

12.

Tau as a therapeutic target in neurodegenerative disease.

Himmelstein DS, Ward SM, Lancia JK, Patterson KR, Binder LI.

Pharmacol Ther. 2012 Oct;136(1):8-22. doi: 10.1016/j.pharmthera.2012.07.001. Epub 2012 Jul 10. Review.

13.
14.

Tau-based treatment strategies in neurodegenerative diseases.

Schneider A, Mandelkow E.

Neurotherapeutics. 2008 Jul;5(3):443-57. doi: 10.1016/j.nurt.2008.05.006. Review.

PMID:
18625456
15.

Quantitative analysis of MAP-mediated regulation of microtubule dynamic instability in vitro focus on Tau.

Kiris E, Ventimiglia D, Feinstein SC.

Methods Cell Biol. 2010;95:481-503. doi: 10.1016/S0091-679X(10)95024-3. Review.

PMID:
20466149
16.
17.

Tau and axonopathy in neurodegenerative disorders.

Higuchi M, Lee VM, Trojanowski JQ.

Neuromolecular Med. 2002;2(2):131-50. Review.

PMID:
12428808
18.

Microtubule-associated protein tau as a therapeutic target in neurodegenerative disease.

Roder HM, Hutton ML.

Expert Opin Ther Targets. 2007 Apr;11(4):435-42. Review.

PMID:
17373874
19.

[Research progress of abnormal phosphorylation of microtubule-associated tau protein and of the targeted inhibition of the phosphorylation].

Zhou F, Chen S, Sun X.

Sheng Wu Yi Xue Gong Cheng Xue Za Zhi. 2012 Aug;29(4):788-92. Review. Chinese.

PMID:
23016437
20.

Endoplasmic reticulum: the unfolded protein response is tangled in neurodegeneration.

Hoozemans JJ, Scheper W.

Int J Biochem Cell Biol. 2012 Aug;44(8):1295-8. doi: 10.1016/j.biocel.2012.04.023. Epub 2012 May 4. Review.

PMID:
22564438
Items per page

Supplemental Content

Write to the Help Desk